Literature DB >> 9869004

Blood pressure in relation to obesity, insulin and the hypothalamic-pituitary-adrenal axis in Swedish men.

R Rosmond1, P Björntorp.   

Abstract

OBJECTIVE: Some studies have shown a clustering of obesity, insulin and hypertension. The present study was performed to further characterize these associations. SUBJECTS AND METHODS: In a population of 51-year-old men (n=284), measurements of systolic and diastolic blood pressure were analyzed in relation to general obesity (body mass index) and central obesity (waist: hip circumference ratio and abdominal sagittal diameter), and to the fasting insulin and insulin: glucose ratio as an approximation of insulin sensitivity. The regulation of diurnal cortisol secretion was examined in repeated salivary samples.
RESULTS: Linear regression analysis showed that all three parameters of obesity were significantly and strongly related to both systolic and diastolic blood pressure, more powerfully than insulin, glucose and insulin sensitivity (insulin: glucose ratio). Stepwise multiple regression showed that only central obesity, measured as the abdominal sagittal diameter, remained significantly (P< 0.001), and independently of insulin and insulin sensitivity, associated with both systolic and diastolic blood pressure (beta=7.5 and 4.2, respectively). A diurnal cortisol curve with normal rhythm was associated with lower than average blood pressures (P< 0.001) but not with insulin levels or the heart rate. In contrast, a flattened diurnal cortisol curve, indicating perturbations in the activity of the hypothalamic-pituitary-adrenal axis, was directly related to blood pressures, heart rate and insulin (P<0.001), and has previously been found to be strongly associated with abdominal obesity.
CONCLUSIONS: These findings suggest that general and central obesity is independently related to blood pressure, and that insulin may account for only part of this association. The activity of the hypothalamic-pituitary-adrenal axis is apparently important for blood pressure regulation, suggesting that mechanisms of the central nervous system have an impact.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9869004     DOI: 10.1097/00004872-199816120-00003

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  6 in total

1.  Antenatal glucocorticoid treatment is associated with diurnal cortisol regulation in term-born children.

Authors:  M N Edelmann; C A Sandman; L M Glynn; D A Wing; E P Davis
Journal:  Psychoneuroendocrinology       Date:  2016-06-23       Impact factor: 4.905

Review 2.  Bipolar disorder and the metabolic syndrome: causal factors, psychiatric outcomes and economic burden.

Authors:  Andrea Fagiolini; K N Roy Chengappa; Isabella Soreca; Jane Chang
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

3.  Association between the metabolic syndrome and serum cortisol in overweight Latino youth.

Authors:  Marc J Weigensberg; Claudia M Toledo-Corral; Michael I Goran
Journal:  J Clin Endocrinol Metab       Date:  2008-02-05       Impact factor: 5.958

4.  Association between Higher Serum Cortisol Levels and Decreased Insulin Secretion in a General Population.

Authors:  Aya Kamba; Makoto Daimon; Hiroshi Murakami; Hideyuki Otaka; Kota Matsuki; Eri Sato; Jutaro Tanabe; Shinobu Takayasu; Yuki Matsuhashi; Miyuki Yanagimachi; Ken Terui; Kazunori Kageyama; Itoyo Tokuda; Ippei Takahashi; Shigeyuki Nakaji
Journal:  PLoS One       Date:  2016-11-18       Impact factor: 3.240

5.  The relationships of leptin, adiponectin levels and paraoxonase activity with metabolic and cardiovascular risk factors in females treated with psychiatric drugs.

Authors:  Aliye Ozenoglu; Huriye Balci; Serdal Ugurlu; Erkan Caglar; Hafize Uzun; Cihat Sarkis; Can Gunay; Engin Eker E
Journal:  Clinics (Sao Paulo)       Date:  2008-10       Impact factor: 2.365

6.  Dominance of the hypothalamus-pituitary-adrenal axis over the renin-angiotensin-aldosterone system is a risk factor for decreased insulin secretion.

Authors:  Makoto Daimon; Aya Kamba; Hiroshi Murakami; Satoru Mizushiri; Sho Osonoi; Kota Matsuki; Eri Sato; Jutaro Tanabe; Shinobu Takayasu; Yuki Matsuhashi; Miyuki Yanagimachi; Ken Terui; Kazunori Kageyama; Itoyo Tokuda; Shizuka Kurauchi; Shigeyuki Nakaji
Journal:  Sci Rep       Date:  2017-09-12       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.